Učitavanje...

Clinical utility of survivin (BIRC5), novel cardiac biomarker, as a prognostic tool compared to high-sensitivity C-reactive protein, heart-type fatty acid binding protein and revised Lee score in elderly patients scheduled for major non-cardiac surgery: A prospective pilot study

Background: Recent studies indicate that survivin (BIRC5) is sensitive to the existence of previous ischemic heart disease, since it is activated in the process of tissue repair and angiogenesis. The aim of this study was to determine the potential of survivin (BIRC5) as a new cardiac biomarker in t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Marković Danica, Jevtović-Stoimenov Tatjana, Ćosić Vladan S., Stošić Biljana, Dinić Vesna, Marković-Živković Bojana, Janković Radmilo J.
Format: Artigo
Jezik:Inglês
Izdano: Society of Medical Biochemists of Serbia, Belgrade 2018-01-01
Serija:Journal of Medical Biochemistry
Teme:
Online pristup:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2018/1452-82581802110M.pdf
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!